vs
AEHR TEST SYSTEMS（AEHR）与太平洋生物科学（ASMB）财务数据对比。点击上方公司名可切换其他公司
太平洋生物科学的季度营收约是AEHR TEST SYSTEMS的1.1倍（$10.8M vs $9.9M），AEHR TEST SYSTEMS净利率更高（-32.7% vs -85.2%，领先52.6%），太平洋生物科学同比增速更快（57.6% vs -26.5%），AEHR TEST SYSTEMS自由现金流更多（$-1.6M vs $-15.2M）
Aehr Test Systems是全球半导体测试领域供应商，主要设计、生产和销售先进的半导体老化测试设备，服务于芯片制造商、封测厂商及芯片设计企业，产品用于逻辑芯片、存储芯片、功率半导体的可靠性验证，业务覆盖北美、亚洲、欧洲等主要市场。
该公司是一家成立于2004年的美国生物科技企业，主要研发生产基因测序相关设备，同时也开展新型实时生物观测技术相关业务。目前拥有两大核心测序平台，分别是基于零模波导特性的单分子实时测序平台，以及结合天然核苷酸无痕连接技术的结合测序平台。
AEHR vs ASMB — 直观对比
营收规模更大
ASMB
是对方的1.1倍
$9.9M
营收增速更快
ASMB
高出84.1%
-26.5%
净利率更高
AEHR
高出52.6%
-85.2%
自由现金流更多
AEHR
多$13.5M
$-15.2M
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $9.9M | $10.8M |
| 净利润 | $-3.2M | $-9.2M |
| 毛利率 | 25.7% | — |
| 营业利润率 | -47.0% | -100.9% |
| 净利率 | -32.7% | -85.2% |
| 营收同比 | -26.5% | 57.6% |
| 净利润同比 | -214.2% | 4.3% |
| 每股收益（稀释后） | $-0.11 | $-0.72 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AEHRASMB
| Q4 25 | $9.9M | — | ||
| Q3 25 | $11.0M | $10.8M | ||
| Q2 25 | $14.1M | $9.6M | ||
| Q1 25 | $18.3M | $9.4M | ||
| Q4 24 | $13.5M | $7.4M | ||
| Q3 24 | $13.1M | $6.8M | ||
| Q2 24 | $16.6M | $8.5M | ||
| Q1 24 | $7.6M | $5.8M |
净利润AEHRASMB
| Q4 25 | $-3.2M | — | ||
| Q3 25 | $-2.1M | $-9.2M | ||
| Q2 25 | $-2.9M | $-10.2M | ||
| Q1 25 | $-643.0K | $-8.8M | ||
| Q4 24 | $-1.0M | — | ||
| Q3 24 | $660.0K | $-9.6M | ||
| Q2 24 | $23.9M | $-11.2M | ||
| Q1 24 | $-1.5M | $-9.1M |
毛利率AEHRASMB
| Q4 25 | 25.7% | — | ||
| Q3 25 | 33.9% | — | ||
| Q2 25 | 30.3% | — | ||
| Q1 25 | 39.2% | — | ||
| Q4 24 | 40.1% | — | ||
| Q3 24 | 54.0% | — | ||
| Q2 24 | 50.9% | — | ||
| Q1 24 | 41.7% | — |
营业利润率AEHRASMB
| Q4 25 | -47.0% | — | ||
| Q3 25 | -37.1% | -100.9% | ||
| Q2 25 | -22.7% | -115.2% | ||
| Q1 25 | -6.1% | -105.5% | ||
| Q4 24 | -11.2% | — | ||
| Q3 24 | 1.2% | -160.1% | ||
| Q2 24 | 15.3% | -143.0% | ||
| Q1 24 | -27.1% | -185.5% |
净利率AEHRASMB
| Q4 25 | -32.7% | — | ||
| Q3 25 | -19.0% | -85.2% | ||
| Q2 25 | -20.6% | -105.9% | ||
| Q1 25 | -3.5% | -93.6% | ||
| Q4 24 | -7.6% | — | ||
| Q3 24 | 5.0% | -140.4% | ||
| Q2 24 | 143.8% | -130.7% | ||
| Q1 24 | -19.4% | -156.9% |
每股收益（稀释后）AEHRASMB
| Q4 25 | $-0.11 | — | ||
| Q3 25 | $-0.07 | $-0.72 | ||
| Q2 25 | $-0.10 | $-1.33 | ||
| Q1 25 | $-0.02 | $-1.17 | ||
| Q4 24 | $-0.03 | — | ||
| Q3 24 | $0.02 | $-1.51 | ||
| Q2 24 | $0.81 | $-1.98 | ||
| Q1 24 | $-0.05 | $-1.66 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $30.8M | $22.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $130.8M | $182.7M |
| 总资产 | $148.7M | $240.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AEHRASMB
| Q4 25 | $30.8M | — | ||
| Q3 25 | $22.7M | $22.5M | ||
| Q2 25 | $24.5M | $24.0M | ||
| Q1 25 | $29.4M | $23.4M | ||
| Q4 24 | $32.2M | $38.3M | ||
| Q3 24 | $37.8M | $28.5M | ||
| Q2 24 | $49.2M | $19.2M | ||
| Q1 24 | $47.6M | $18.7M |
股东权益AEHRASMB
| Q4 25 | $130.8M | — | ||
| Q3 25 | $122.4M | $182.7M | ||
| Q2 25 | $122.9M | $18.1M | ||
| Q1 25 | $124.2M | $27.1M | ||
| Q4 24 | $123.2M | $33.4M | ||
| Q3 24 | $122.5M | $26.0M | ||
| Q2 24 | $111.6M | $34.7M | ||
| Q1 24 | $86.5M | $32.6M |
总资产AEHRASMB
| Q4 25 | $148.7M | — | ||
| Q3 25 | $144.1M | $240.0M | ||
| Q2 25 | $148.5M | $80.8M | ||
| Q1 25 | $145.6M | $99.0M | ||
| Q4 24 | $142.3M | $119.2M | ||
| Q3 24 | $145.9M | $100.3M | ||
| Q2 24 | $127.9M | $115.3M | ||
| Q1 24 | $101.6M | $119.9M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.2M | $-15.1M |
| 自由现金流经营现金流 - 资本支出 | $-1.6M | $-15.2M |
| 自由现金流率自由现金流/营收 | -16.6% | -140.7% |
| 资本支出强度资本支出/营收 | 4.7% | 0.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-11.7M | — |
8季度趋势，按日历期对齐
经营现金流AEHRASMB
| Q4 25 | $-1.2M | — | ||
| Q3 25 | $-282.0K | $-15.1M | ||
| Q2 25 | $-2.3M | $-16.8M | ||
| Q1 25 | $-1.6M | $-23.4M | ||
| Q4 24 | $-5.9M | $-51.1M | ||
| Q3 24 | $2.4M | $-15.2M | ||
| Q2 24 | $1.2M | $-17.1M | ||
| Q1 24 | $-2.8M | $-18.4M |
自由现金流AEHRASMB
| Q4 25 | $-1.6M | — | ||
| Q3 25 | $-1.7M | $-15.2M | ||
| Q2 25 | $-5.1M | — | ||
| Q1 25 | $-3.3M | — | ||
| Q4 24 | $-6.2M | $-51.1M | ||
| Q3 24 | $2.2M | — | ||
| Q2 24 | $1.2M | $-17.1M | ||
| Q1 24 | $-3.1M | $-18.4M |
自由现金流率AEHRASMB
| Q4 25 | -16.6% | — | ||
| Q3 25 | -15.3% | -140.7% | ||
| Q2 25 | -36.3% | — | ||
| Q1 25 | -17.8% | — | ||
| Q4 24 | -46.0% | -695.2% | ||
| Q3 24 | 16.6% | — | ||
| Q2 24 | 7.1% | -200.6% | ||
| Q1 24 | -40.8% | -317.7% |
资本支出强度AEHRASMB
| Q4 25 | 4.7% | — | ||
| Q3 25 | 12.7% | 0.4% | ||
| Q2 25 | 20.0% | 0.0% | ||
| Q1 25 | 9.0% | 0.0% | ||
| Q4 24 | 2.4% | 0.4% | ||
| Q3 24 | 1.5% | 0.0% | ||
| Q2 24 | 0.3% | 0.2% | ||
| Q1 24 | 3.5% | 0.2% |
现金转化率AEHRASMB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.61× | — | ||
| Q2 24 | 0.05× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AEHR
| Systems | $5.0M | 50% |
| Contactors | $3.4M | 35% |
| Services | $1.5M | 15% |
ASMB
暂无分部数据
